A detailed history of O'Shaughnessy Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 292,949 shares of NVO stock, worth $29.8 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
292,949
Previous 252,465 16.04%
Holding current value
$29.8 Million
Previous $36 Million 3.21%
% of portfolio
0.32%
Previous 0.38%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $4.82 Million - $5.89 Million
40,484 Added 16.04%
292,949 $34.9 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $1.76 Million - $2.1 Million
14,314 Added 6.01%
252,465 $36 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $2.74 Million - $3.65 Million
26,830 Added 12.7%
238,151 $30.6 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $750,782 - $901,913
8,553 Added 4.22%
211,321 $21.9 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $8.98 Million - $19.7 Million
98,695 Added 94.83%
202,768 $18.4 Million
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $907,023 - $1 Million
5,815 Added 5.92%
104,073 $16.8 Million
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $934,188 - $1.12 Million
7,059 Added 7.74%
98,258 $15.6 Million
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $1.27 Million - $1.68 Million
12,408 Added 15.75%
91,199 $12.3 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $83,465 - $102,430
-876 Reduced 1.1%
78,791 $7.85 Million
Q2 2022

Aug 11, 2022

BUY
$103.24 - $121.81 $1.35 Million - $1.6 Million
13,095 Added 19.67%
79,667 $8.88 Million
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $1.64 Million - $1.99 Million
17,659 Added 36.1%
66,572 $7.39 Million
Q4 2021

Feb 11, 2022

BUY
$95.88 - $117.08 $972,319 - $1.19 Million
10,141 Added 26.16%
48,913 $5.48 Million
Q3 2021

Nov 10, 2021

BUY
$84.42 - $106.62 $1.22 Million - $1.54 Million
14,398 Added 59.07%
38,772 $3.72 Million
Q2 2021

Aug 09, 2021

SELL
$67.66 - $84.76 $132,478 - $165,960
-1,958 Reduced 7.44%
24,374 $2.04 Million
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $539,028 - $609,441
8,038 Added 43.94%
26,332 $1.78 Million
Q4 2020

Feb 11, 2021

BUY
$63.89 - $73.8 $142,155 - $164,205
2,225 Added 13.85%
18,294 $1.28 Million
Q3 2020

Nov 12, 2020

BUY
$63.69 - $70.22 $191,897 - $211,572
3,013 Added 23.08%
16,069 $1.12 Million
Q2 2020

Aug 13, 2020

BUY
$58.54 - $67.94 $578,843 - $671,790
9,888 Added 312.12%
13,056 $855,000
Q1 2020

May 13, 2020

SELL
$49.46 - $64.78 $39,122 - $51,240
-791 Reduced 19.98%
3,168 $191,000
Q4 2019

Feb 12, 2020

BUY
$49.86 - $58.26 $197,146 - $230,360
3,954 Added 79080.0%
3,959 $229,000
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $142 - $160
3 Added 150.0%
5 $0
Q2 2019

Aug 07, 2019

BUY
$46.79 - $52.47 $93 - $104
2 New
2 $0
Q1 2019

May 10, 2019

SELL
$46.36 - $52.63 $312,234 - $354,463
-6,735 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$41.54 - $47.25 $307,686 - $349,980
-7,407 Reduced 52.38%
6,735 $310,000
Q3 2018

Nov 06, 2018

SELL
$46.76 - $51.24 $344,247 - $377,228
-7,362 Reduced 34.24%
14,142 $667,000
Q2 2018

Aug 10, 2018

SELL
$44.29 - $50.42 $2,701 - $3,075
-61 Reduced 0.28%
21,504 $992,000
Q1 2018

May 08, 2018

BUY
$48.49 - $58.14 $216,992 - $260,176
4,475 Added 26.18%
21,565 $1.06 Million
Q4 2017

Feb 13, 2018

BUY
$47.53 - $53.73 $190,167 - $214,973
4,001 Added 30.57%
17,090 $917,000
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $344,960 - $412,611
8,383 Added 178.13%
13,089 $630,000
Q2 2017

Aug 14, 2017

BUY
N/A
4,706
4,706 $202,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.